Phenominer Database Results (15 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Experiment Notes Record ID Study ID
BDIX/CrCrl blood hemoglobin level DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 92 days 10 18.9 g/dl 0.47 1.5 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107833 3097
BDIX/CrCrl mean corpuscular hemoglobin DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 92 days 10 17.7 pg 0.22 0.7 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107839 3097
BDIX/CrCrl blood hemoglobin level DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 92 days 10 16.6 g/dl 0.32 1.0 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107834 3097
BDIX/CrCrl mean corpuscular hemoglobin DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 71 days 10 18.0 pg 0.06 0.2 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107836 3097
BDIX/CrCrl blood hemoglobin level DHD/K12/TRb cells (1.5 X 10E6) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 56 days 20 18.1 g/dl 0.02 0.1 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107830 3097
BDIX/CrCrl mean corpuscular hemoglobin concentration DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 92 days 10 37.0 g/dl 0.19 0.6 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107843 3097
BDIX/CrCrl blood hemoglobin level DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 71 days 10 20.1 g/dl 0.28 0.9 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107832 3097
BDIX/CrCrl mean corpuscular hemoglobin DHD/K12/TRb cells (1.5 X 10E6) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 56 days 20 17.9 pg 0.02 0.1 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107835 3097
BDIX/CrCrl mean corpuscular hemoglobin DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 92 days 10 17.5 pg 0.03 0.1 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107838 3097
BDIX/CrCrl mean corpuscular hemoglobin concentration DHD/K12/TRb cells (1.5 X 10E6) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 56 days 20 38.1 g/dl 0.02 0.1 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107840 3097
BDIX/CrCrl mean corpuscular hemoglobin concentration DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 71 days 10 38.0 g/dl 0.13 0.4 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107841 3097
BDIX/CrCrl blood hemoglobin level DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 71 days 10 19.9 g/dl 0.66 2.1 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107831 3097
BDIX/CrCrl mean corpuscular hemoglobin DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 71 days 10 18.3 pg 0.13 0.4 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107837 3097
BDIX/CrCrl mean corpuscular hemoglobin concentration DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 71 days 10 38.2 g/dl 0.03 0.1 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107842 3097
BDIX/CrCrl mean corpuscular hemoglobin concentration DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. blood hemoglobin amount male 92 days 10 37.7 g/dl 0.51 1.6 blood hemoglobin analysis 0.0 0 hemoglobin, MCH, MCHC 107844 3097